Prospeo
Hero Section BackgroundHero Section Background
EpiVax

EpiVax Email Formats

Biotechnology ResearchFlag of USProvidence, Rhode Island, United States21-50 Employees

EpiVax Email Formats

EpiVax uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@epivax.com), used 66.7% of the time.

FormatExamplePercentage
{first initial}{last name}
jdoe@epivax.com
66.7%
{first name}{last name}
johndoe@epivax.com
28.2%
{first initial}
j@epivax.com
5.1%

Key Contacts at EpiVax

Flag of US

Annie De Groot

Founder And Cso, Chairman Of The Board

Flag of US

Leaya Martelli

Director Of Human Resources

Flag of US

Rich-Henry Schabowsky

Chief Executive Officer

Flag of US

Amy Rosenberg

Senior Director Of Immunology And Consultant

Flag of US

Aimee Mattei

Director Of Bioinformatics

Flag of US

Guilhem Richard

Chief Technology Officer

Flag of US

Christine Boyle

Senior Director Of Scientific Operations

Flag of US

Epivax Inc

Owner

Company overview

Headquarters188 Valley St, Providence, Rhode Island 02909, US
Phone number+14012722123
Website
NAICS541714
SIC283
Keywords
Deimmunization, Cancer Vaccines, Computational Immunology, Immunogenicity Screening, Vaccine Design, Immune Engineering, Animal Health Vaccines, Biologics Research And Development, Immunogenicity Risk Assessment, In Silico Prediction
Founded1998
Employees21-50
Socials

About EpiVax

EpiVax leads the industry in preclinical immunogenicity assessment and sequence optimization for biologic therapeutics and vaccines. Utilizing proprietary methods for T cell epitope identification and characterization, we employ a wide range of validated in silico and in vitro techniques. This comprehensive approach provides accurate and thorough insights into immunogenic potential, ensuring the efficacy and safety of our clients’ products. Headquartered in Providence, RI, EpiVax has been pushing the boundaries of computational immunology for over 25 years. Our expert team of scientists have developed broad analytical capabilities, empowering pharmaceutical developers to make well informed decisions. The goal is to aid in the development of next generation treatments by offering cutting-edge methods. We believe in the power of science to transform human and animal health worldwide. Our motto, “Fearless Science,” embodies our commitment to boldly advancing research, overcoming challenges, and driving progress in immunology. We invite you to join us in shaping a healthier future, where science knows no limits. For more information, visit www.epivax.com

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry
Manager
C-Suite

Employees by Department

EpiVax has 34 employees across 12 departments.

Departments

Number of employees

Funding Data

Explore EpiVax's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2022-10-129$2,000,000

Funding Insights

$2,000,000

Total funding amount

$2,000,000

Most recent funding amount

1

Number of funding rounds

EpiVax Tech Stack

Discover the technologies and tools that power EpiVax's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

MediaElement.js

Video players

reCAPTCHA

reCAPTCHA

Security

parcel

parcel

Miscellaneous

Cloudflare Bot Management

Cloudflare Bot Management

Security

Site Kit

Site Kit

Analytics

jQuery Mobile

jQuery Mobile

Mobile frameworks

SWC

SWC

Miscellaneous

Microsoft 365

Microsoft 365

Email

jQuery Migrate

jQuery Migrate

JavaScript libraries

Cloudflare

Cloudflare

CDN

jQuery

jQuery

JavaScript libraries

HubSpot Analytics

HubSpot Analytics

Analytics

Frequently asked questions

EpiVax is located in Providence, Rhode Island, US.
You can reach EpiVax at +14012722123.
EpiVax was founded in 1998, making it 28 years old. The company has established itself as a significant player in its industry over this time.
EpiVax has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.
EpiVax has raised a total of $2,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles